跳至主要内容
临床试验/JPRN-UMIN000036119
JPRN-UMIN000036119已完成未知

A comparative study of renoprotective effect of tolvaptan as an alternative treatment for increasing loop diuretics in patients with chronic kidney disease complicated with chronic heart failure - A comparative study of renoprotective effect of tolvaptan as an alternative treatment for increasing loop diuretics in patients with chronic kidney disease complicated with chronic heart failure

Kawashima hospital0 个研究点目标入组 40 人开始时间: 2019年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who cannot intake fluids or feel thirst Patients with anuria or urinary excretion disorder Patients with hypernatremia Patients with serious hepatic disorder Patients under the pacing therapy Patients with percutaneous coronary intervention or open heart surgery within the past 3 months Patients with poorly controlled diabetes mellitus Patients who take SGLT-2 inhibitor Patients who are pregnant or possibly pregnant Patients without agreement on enrolment of this study Inappropriate patients judged by doctor

研究者

相似试验

A comparative study of renoprotective effect of... | 临床试验